Diagnostic endoscopic resection as first-line management for grade 1–2 duodenal neuroendocrine tumors: a retrospective study
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q3
- 저널
- SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY60(9) · pp.847 · 2025
- 피인용
- Web of Science 0Scopus 0
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2024 1.7
- ISSN
- 0036-5521
저자
- 이철민제1저자Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea
- 최철웅교신저자Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea
- 유대곤Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea
- 김수진Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea
- 박수범Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea
- 장진욱Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea
- 최은정Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea
- 정재헌Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan 50612, Gyeongsangnam, South Korea
- 이시학Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan 50612, Gyeongsangnam, South Korea
- 황순휘Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan 50612, Gyeongsangnam, South Korea
초록
Objectives: Duodenal neuroendocrine tumors are increasingly identified incidentally during screening endoscopy. While surgical resection is standard, the role of endoscopic resection, particularly for grade 1 and 2 tumors, remains under discussion. This study aimed to evaluate the feasibility and outcomes of diagnostic endoscopic resection in grade 1 or 2 duodenal neuroendocrine tumors. Methods: We retrospectively reviewed 40 patients with grade 1 or 2 duodenal neuroendocrine tumors treated at a single tertiary center between November 2008 and July 2023. Clinical, endoscopic, and histopathologic features were analyzed, including resection methods, complications, and long-term outcomes. Results: The mean tumor size was 7.4 ± 0.9 mm, with 80% of tumors <10 mm. Grade 1 tumors accounted for 90% of the cases. Endoscopic resection was performed in 28 patients; ligation-assisted endoscopic mucosal resection achieved a 100% complete (R0) resection rate. One patient had a perforation, which was successfully managed endoscopically. Five patients did not undergo resection following forceps biopsy. Two patients required additional surgery after endoscopic resection, and 7 underwent primary surgery. No patient exhibited lymph node or distant metastasis, and no recurrence was observed during a mean follow-up period of 59.0 ± 6.9 months. Conclusions: Endoscopic resection may be a safe and effective first-line treatment for grade 1 or 2 duodenal neuroendocrine tumors, including selected lesions >10 mm. Ligation-assisted endoscopic mucosal resection may be preferred for subcentimeter lesions. Diagnostic endoscopic resection should be considered in selected patients to avoid unnecessary surgery.
키워드
diagnosisduodenumendoscopyNeuroendocrine tumorresectionYIELDNETSCLIP
식별자
- Scopus EID
- 2-s2.0-105012251601
- WoS UID
- 001538691400001



로그인
연구물 목록으로